Literature DB >> 6308222

Purine receptors in the rat anococcygeus muscle.

T W Stone.   

Abstract

Adenosine triphosphate (ATP) caused contraction of the resting isolated rat anococcygeus muscle. Non-phosphorylated purines did not cause contraction of the resting muscle but did so in muscles in which the tone was raised by carbachol or guanethidine. Adenosine, (-)N6-phenylisopropyladenosine (PIA) and 5'-N-ethyl-carboxamide adenosine (NECA) were approximately equipotent, and these responses were not prevented by theophylline, quinidine, 2,2'-pyridylisatogen tosylate, phentolamine, methysergide, dipyridamole, hexobendine or indomethacin. The contractions became smaller as muscle tone progressively declined, and it is suggested that this effect may explain the apparent blockade of ATP responses by indomethacin reported previously. Adenosine, 2-chloroadenosine, ATP, PIA and NECA inhibited contractile responses of the anococcygeus to field stimulation of the excitatory adrenergic innervation. This inhibitory action was blocked by theophylline, and as PIA was easily the most potent purine tested, it may involve activation of an A1/Ri receptor. It is also argued, however, that the A/R scheme of classification may be inappropriate for the description of responses of intact tissues. As response to noradrenaline were not changed by the purines, the inhibitory effect on stimulation-evoked contractions is probably mediated at a presynaptic site. None of the purines tested had any effect on the neurally mediated inhibition of the anococcygeus which is seen when intrinsic tone is raised and the excitatory adrenergic nerves are blocked.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308222      PMCID: PMC1197372          DOI: 10.1113/jphysiol.1983.sp014553

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  70 in total

1.  Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca2+ influx.

Authors:  J Schrader; R Rubio; R M Berne
Journal:  J Mol Cell Cardiol       Date:  1975-06       Impact factor: 5.000

2.  Evidence that prostaglandin is responsible for the 'rebound contraction' following stimulation of non-adrenergic, non-cholinergic ('purinergic') inhibitory nerves.

Authors:  G Burnstock; T Cocks; B Paddle; J Staszewska-Barczak
Journal:  Eur J Pharmacol       Date:  1975-04       Impact factor: 4.432

3.  Antagonism of adenosine 5'-triphosphate-induced relaxation by 2-2'-pyridylisatogen in the taenia of guinea-pig caecum.

Authors:  M Spedding; A J Sweetman; D F Weetman
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

4.  Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline.

Authors:  J Sawynok; K H Jhamandas
Journal:  J Pharmacol Exp Ther       Date:  1976-05       Impact factor: 4.030

5.  Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs.

Authors:  P Needleman; M S Minkes; J R Douglas
Journal:  Circ Res       Date:  1974-04       Impact factor: 17.367

Review 6.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

7.  A species difference in the uptake of adenosine by heart.

Authors:  S V Hopkins; R G Goldie
Journal:  Biochem Pharmacol       Date:  1971-12       Impact factor: 5.858

8.  Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds.

Authors:  D Satchell; G Burnstock; P Dann
Journal:  Eur J Pharmacol       Date:  1973-09       Impact factor: 4.432

9.  The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.

Authors:  B L Ginsborg; G D Hirst
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

10.  The rat anococcygeus muscle and its response to nerve stimulation and to some drugs.

Authors:  J S Gillespie
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  9 in total

1.  Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae.

Authors:  S J Bailey; D Hickman; S M Hourani
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

2.  Adenosine receptors involved in the inhibitory control of non-adrenergic non-cholinergic neurotransmission in guinea-pig atria belong to the A1 subtype.

Authors:  A Rubino; S Amerini; L Mantelli; F Ledda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

3.  Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.

Authors:  A T Najbar; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction.

Authors:  J A Ribeiro; A M Sebastião
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

5.  A study of the purinoceptors mediating contraction in the rat colon.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  Presynaptic P1-purinoceptors in jejunal branches of the rabbit mesenteric artery and their possible function.

Authors:  P Illes; R Jackisch; J T Regenold
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

7.  On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

8.  Inhibition by purines of the inotropic action of isoprenaline in rat atria.

Authors:  P R Hughes; T W Stone
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

9.  Potentiation of miniature endplate potential frequency by ATP in Xenopus tadpoles.

Authors:  W M Fu; S H Yang; S Y Lin-Shiau
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.